HighTower Advisors, LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$5,253,000
+36.7%
199,236
-10.9%
0.01%
+25.0%
Q2 2023$3,844,000
+11.2%
223,613
+7.2%
0.01%0.0%
Q1 2023$3,457,000
+117.7%
208,613
+0.1%
0.01%
+100.0%
Q4 2022$1,588,000
-23.3%
208,3850.0%0.00%
-33.3%
Q3 2022$2,071,000
+9.5%
208,3850.0%0.01%
+20.0%
Q2 2022$1,891,000
-10.6%
208,385
+0.1%
0.01%0.0%
Q1 2022$2,115,000
-42.1%
208,270
-4.9%
0.01%
-37.5%
Q4 2021$3,652,000
-63.2%
218,922
+3.4%
0.01%
-70.4%
Q3 2021$9,920,000
-26.6%
211,638
-4.6%
0.03%
-30.8%
Q2 2021$13,520,000
-1.0%
221,768
+0.0%
0.04%
-9.3%
Q1 2021$13,661,000
-12.8%
221,765
+0.6%
0.04%
-33.8%
Q4 2020$15,672,000
+89.6%
220,408
+0.0%
0.06%
+62.5%
Q3 2020$8,267,000
+15.1%
220,3080.0%0.04%
+2.6%
Q2 2020$7,184,000
+12.4%
220,3080.0%0.04%
-4.9%
Q1 2020$6,390,000220,3080.04%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$55,099,00039.31%
M28 Capital Management LP 466,200$4,233,0004.74%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$282,034,0003.75%
Octagon Capital Advisors LP 933,743$8,478,0002.26%
VIKING GLOBAL INVESTORS LP 26,620,991$241,719,0001.11%
HHLR ADVISORS, LTD. 5,362,014$48,687,0001.04%
Cormorant Asset Management, LP 1,469,179$13,340,0001.01%
Knott David M Jr 213,206$1,936,0000.81%
Fernwood Investment Management, LLC 183,900$1,670,0000.72%
HighVista Strategies LLC 105,942$962,0000.58%
View complete list of BRIDGEBIO PHARMA INC shareholders